GALIMI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 2.693
EU - Europa 1.213
AS - Asia 854
OC - Oceania 19
AF - Africa 8
SA - Sud America 5
Totale 4.792
Nazione #
US - Stati Uniti d'America 2.643
CN - Cina 507
IT - Italia 391
DE - Germania 156
IE - Irlanda 108
GB - Regno Unito 96
SG - Singapore 77
SE - Svezia 74
JP - Giappone 68
FI - Finlandia 62
FR - Francia 54
AT - Austria 50
CA - Canada 43
UA - Ucraina 43
IN - India 41
PL - Polonia 39
KR - Corea 34
NL - Olanda 26
HK - Hong Kong 25
VN - Vietnam 21
BE - Belgio 20
ES - Italia 19
ID - Indonesia 18
AU - Australia 17
TW - Taiwan 17
CH - Svizzera 14
RU - Federazione Russa 14
TR - Turchia 13
IR - Iran 9
DK - Danimarca 8
RO - Romania 8
TH - Thailandia 8
CZ - Repubblica Ceca 6
NO - Norvegia 6
MX - Messico 5
GR - Grecia 4
UZ - Uzbekistan 4
CO - Colombia 3
EE - Estonia 3
HU - Ungheria 3
LK - Sri Lanka 3
ZA - Sudafrica 3
DM - Dominica 2
EG - Egitto 2
IL - Israele 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
GH - Ghana 1
IM - Isola di Man 1
KZ - Kazakistan 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
Totale 4.792
Città #
Ann Arbor 509
Chandler 283
Fairfield 261
Beijing 145
Ashburn 135
Seattle 118
Woodbridge 116
Houston 102
Dublin 94
Wilmington 88
Cambridge 87
Torino 83
Shanghai 69
Singapore 51
Pisa 48
Vienna 48
Dearborn 41
Nyköping 36
Redwood City 35
Tokyo 30
Warsaw 30
New York 29
Jacksonville 28
Princeton 26
Milan 24
Villeurbanne 24
Los Angeles 23
Guangzhou 22
Medford 22
Turin 21
Nanjing 19
Boardman 18
Brussels 18
San Diego 18
Jakarta 16
Taipei 16
Manchester 15
Ottawa 15
Changsha 14
Fremont 14
Lappeenranta 14
Naples 14
Boston 13
Hangzhou 13
Helsinki 13
London 13
Genoa 12
Munich 12
Toronto 12
Dong Ket 11
Nanchang 11
Luni 10
Rome 10
Shenyang 10
Wuhan 10
Amsterdam 9
Chongqing 9
Seoul 9
Paris 8
Salt Lake City 8
Austin 7
Chengdu 7
Duncan 7
Fuzhou 7
Zhengzhou 7
Buffalo 6
Central 6
Chicago 6
Eitensheim 6
Heidelberg 6
Kocaeli 6
Nashville 6
Pittsburgh 6
Shenzhen 6
Silver Spring 6
Zurich 6
Bangkok 5
Barcelona 5
Bethesda 5
Birmingham 5
Changchun 5
Gurgaon 5
Hong Kong 5
Madison 5
Melbourne 5
Moscow 5
Berlin 4
Bologna 4
Brookline 4
Chatsworth 4
Columbus 4
Delhi 4
Düsseldorf 4
Falls Church 4
Frankfurt am Main 4
Galway 4
Jinan 4
Norwalk 4
Regensburg 4
Saint Louis 4
Totale 3.219
Nome #
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 705
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 628
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 327
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 316
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 305
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 269
Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3. 248
Only a subset of Met-activated pathways are required to sustain oncogene addiction 240
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment 239
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 231
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 230
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. 211
Inhibition of Src impairs the growth of met-addicted gastric tumors. 207
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 175
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 165
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours 82
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective 78
Met as a potential therapeutic target in basal-like breast cancer 72
Signaling response to transient redox stress in human isolated T cells: Molecular sensor role of syk kinase and functional involvement of IL2 receptor and L-selectine 72
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 69
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients 16
Totale 4.885
Categoria #
all - tutte 10.292
article - articoli 0
book - libri 0
conference - conferenze 1.326
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020608 0 0 35 102 55 87 80 57 67 49 42 34
2020/2021603 34 50 58 38 32 47 69 38 45 63 32 97
2021/20221.006 110 90 72 98 62 59 87 71 52 62 149 94
2022/2023736 73 77 31 78 52 149 41 64 70 16 44 41
2023/2024563 56 54 35 46 38 51 33 66 16 54 78 36
2024/2025133 26 35 72 0 0 0 0 0 0 0 0 0
Totale 4.885